Intensity Therapeutics, Inc.
INTS
Rank in Stocks
#29210
Intensity Therapeutics, Inc. is a biotechnology enterprise in the clinical... Intensity Therapeutics, Inc. is a biotechnology enterprise in the clinical development phase, dedicated to discovering, advancing, and commercializing pharmaceutical treatments for solid tumor cancers. The company's primary experimental compound, INT230-6, is presently undergoing Phase 2 clinical trials. This investigational drug targets a range of difficult-to-treat solid tumors, including those affecting the pancreas, colon, bile duct, as well as squamous cell, sarcoma, breast, and liver cancers. Intensity Therapeutics has formed strategic collaborations with major pharmaceutical companies and research institutions: A partnership with Merck Sharpe & Dohme Corp. focuses on evaluating INT230-6 in conjunction with Keytruda for advanced pancreatic, colon, squamous cell, and bile duct malignancies. Another collaboration with Bristol-Myers Squibb Company is dedicated to studying INT230-6 combined with Yervoy in patients suffering from advanced liver, breast, and sarcoma cancers. Furthermore, the company is working with the Ottawa Hospital Research Institute and the Ontario Institute of Cancer Research on a randomized controlled Phase II neoadjuvant study of INT230-6 for women diagnosed with early-stage breast cancer. Established in 2012, Intensity Therapeutics maintains its corporate headquarters in Westport, Connecticut.
Share Price
$3.15
Last synced: 2026-11-09
Market Cap
$8.51M
Change (1 day)
5.00%
Change (1 year)
-75.39%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Intensity Therapeutics, Inc. (INTS)
Category
Healthcare
Stock split history for Intensity Therapeutics, Inc. (INTS)
Intensity Therapeutics, Inc. stock (symbol: INTS) underwent a total of 1 stock splits.
The most recent stock split occurred on Feb 19, 2026.
One INTS share bought prior to Feb 19, 2026 would equal to 0.04 INTS shares today.
The most recent stock split occurred on Feb 19, 2026.
One INTS share bought prior to Feb 19, 2026 would equal to 0.04 INTS shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| 2026-02-19 | 1:25 | x0.04 | x0.04 |
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 1 | x100 |
BE
|
|
| 0 | - |
NL
|
Questions about Intensity Therapeutics, Inc.'s stock splits
How many times has Intensity Therapeutics, Inc. split its stock?
Intensity Therapeutics, Inc. (INTS) has split its stock once, on Feb 19, 2026.
How many shares would one Intensity Therapeutics, Inc. share bought before Feb 19, 2026 be today?
After all its stock splits, one share bought before Feb 19, 2026 would be 0.04 shares today.